Riskpilot← Back to searchSign inGet full accessSOTRASPESIALISTANE AS
ASActiveOrg 883067452Blombakkane 2, 5354 StraumeMedical specialists activities · NACE 8622Est. 20015 employees
Revenue 2024
NOK 2,3M
+11% vs 2023
EBITDA margin
0.7%
+105% vs 2023
Equity ratio
14.1%
Financial strength
Net profit 2024
NOK -6K
+99% vs 2023
| Revenue | NOK 2,3M | +11% |
| EBITDA | NOK 17K | +105% |
| Net profit | NOK -6K | +99% |
| Total assets | NOK 519K | +3% |
| Equity | NOK 73K | -7% |
| Employees | 5 | — |
Legal name
SOTRASPESIALISTANE AS
Org number
883067452
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
6. mars 2001
Share capital
NOK 140 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Tilby og markedsføre legetjenester innenfor diverse spesialfelt og dertil hørende virksomhet.
Address
Blombakkane 2, 5354 Straume
Phone
+4756313760
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 169 | 1 519 | 1 792 | 2 102 | 2 330 |
| Staff expenses | −772 | −764 | −738 | −884 | −846 |
| EBITDA | 298 | −323 | 3 | −341 | 17 |
| Depreciation & amort. | −12 | −8 | −52 | −45 | −23 |
| EBIT | 286 | −331 | −49 | −386 | −6 |
| Net financials | −1 | −2 | 0 | −0 | −0 |
| Profit before tax | 285 | −332 | −49 | −387 | −6 |
| Tax | 62 | −0 | −0 | −0 | −0 |
| Net profit | 223 | −332 | −49 | −387 | −6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 158 | 683 | 642 | 503 | 519 |
| Equity | 847 | 515 | 466 | 79 | 73 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 311 | 168 | 177 | 423 | 446 |
| Total debt | 311 | 168 | 177 | 423 | 446 |
EBITDA margin
0.7%
This company
15.8%
Market median
-96% vs market
20202024
Equity ratio
14.1%
This company
38.2%
Market median
-63% vs market
20202024
Return on equity
-7.8%
This company
18.4%
Market median
-142% vs market
20202024
Net profit margin
-0.2%
This company
8.1%
Market median
-102% vs market
20202024
Asset turnover
4.49×
This company
1.12×
Market median
+301% vs market
20202024
Debt / equity
6.07×
This company
0.62×
Market median
-879% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Chairman | 2026 | |
| Board of Directors | 2026 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 14.29% | 14.29% | 2024 | |
| Individual | 14.29% | 14.29% | 2024 | |
| Company | 14.29% | 14.29% | 2024 | |
| Company | 14.29% | 14.29% | 2024 | |
| Company | 14.29% | 14.29% | 2024 | |
| Individual | 14.29% | 14.29% | 2024 | |
| Individual | 14.29% | 14.29% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SOTRASPESIALISTANE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kathe Helene Aase | Board of Directors | 0 companies |
| Thomas Rogge | Board of Directors | 0 companies |
| Bo Skagen | Chairman | 0 companies |
| Jon Andrew Hardie | Chairman | 0 companies |
| Gunnar Reksten Husebø | Board of Directors | 0 companies |